Montelukast 10 mg

DRUG6 trials

Sponsors

Merck Sharp & Dohme LLC, GlaxoSmithKline, ViiV Healthcare, Liaquat National Hospital & Medical College, Kafrelsheikh University

Conditions

Allergic Rhinitis (AR)AsthmaCirrhosisHIV Infections

Phase 1

Bioequivalence Study of Montelukast 10 mg Tablets

CompletedNCT01943942

GlaxoSmithKlineAsthma

Start: 2010-05-16End: 2010-05-26Updated: 2017-06-15

Evaluation of Pharmacokinetic Interaction Between GSK3640254 and Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin in Healthy Adults

CompletedNCT04425902

ViiV HealthcareHIV Infections

Start: 2020-12-16End: 2021-03-10Updated: 2024-01-05

Phase 2

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012)

TerminatedNCT01656395

Merck Sharp & Dohme LLCAsthma

Start: 2012-08-23End: 2014-07-08Updated: 2018-09-13

Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)

CompletedNCT02720081

Merck Sharp & Dohme LLCAsthma

Start: 2016-05-11End: 2017-09-06Updated: 2018-09-27

Phase 4

A Pilot Study of Mirabegron and Montelukast in Cirrhotic Patients

CompletedNCT07533565

Kafrelsheikh UniversityAsthma, Cirrhosis

Start: 2024-07-01End: 2025-10-01Updated: 2026-04-16

Comparison of Antihistamine and Antileukotriene Add-On Therapy to Intranasal Corticosteroid in Allergic Rhinitis

Not yet recruitingNCT07532993

Liaquat National Hospital & Medical CollegeAllergic Rhinitis (AR)

Start: 2026-09-01End: 2027-05-01Target: 32Updated: 2026-04-16